TrialThe Lancet. Oncology2013

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

Adrian S Dobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.